Public @autismcrisis posts on Bluesky and Twitter/X

This page lists public posts integrated from @autismcrisis.bsky.social on Bluesky and archived posts from Twitter/X in one chronological feed. It supports reading, filtering and structured review of Michelle Dawson’s public posts used in the autism science watch project.

Twitter/X and Bluesky

14991 posts:

Post published on Twitter/X on 17 Jan 2022 13:17

Information about the link integrated into the post

Research project

Kathleen C Gunthert (2022). Cerebellum and autism: Regional specialization for social and executive functions. NIH RePORTER. AMERICAN UNIVERSITY.

Link to cited source
View post record

Post published on Twitter/X on 17 Jan 2022 04:25

Information about the link integrated into the post

DOI work

Victoria Perry, Katherine Ellis, Jo Moss, Sarah R. Beck, Gursharan Singla, Hayley Crawford, Jane Waite, Caroline Richards, et al. (2022). Executive function, repetitive behaviour and restricted interests in neurodevelopmental disorders. Research in Developmental Disabilities, 122, 104166. Elsevier BV.

Link to cited source
View post record

Post published on Twitter/X on 16 Jan 2022 03:35

Information about the link integrated into the post

DOI work

Jessica Suhrheinrich, Allison S Nahmias, Yue Yu, Melina Melgarejo, Patricia Schetter, Tana C Holt, Aubyn C Stahmer (2022). Practice-driven research for statewide scale up: Implementation outcomes of the California Autism Professional Training and Information Network. Autism, 26(3), 727-736. SAGE Publications.

Link to cited source
View post record

Post published on Twitter/X on 15 Jan 2022 12:11

Information about the link integrated into the post

Clinical trial

New York University, Emerson College (2020). Study 2: Learning New Words From Overhearing in Children With Autism Spectrum Disorder (ASD). ClinicalTrials.gov. New York University.

Link to cited source
View post record

Post published on Twitter/X on 15 Jan 2022 05:25

Information about the link integrated into the post

DOI work

Kyongje Sung, Hanna Glazer, Jessica O’Grady, Mindy L. McEntee, Laura Bosley, Dana Boatman Reich, Barry Gordon (2022). Measuring visual electrophysiological responses in individuals with low-functioning autism: a feasibility and pilot study. Pilot and Feasibility Studies, 8(1), 7. Springer Science and Business Media LLC.

Link to cited source
View post record

Post published on Twitter/X on 14 Jan 2022 14:30

Information about the link integrated into the post

DOI work

Iva Ilioska, Marianne Oldehinkel, Alberto Llera, Sidhant Chopra, Tristan Looden, Roselyne Chauvin, Daan van Rooij, Dorothea Floris, et al. (2022). Connectome-wide mega-analysis reveals robust patterns of atypical functional connectivity in autism. openRxiv.

Link to cited source
View post record

Post published on Twitter/X on 14 Jan 2022 03:53

Information about the link integrated into the post

DOI work

Eelke Spaak, Marius V. Peelen, Floris P. de Lange (2022). Scene Context Impairs Perception of Semantically Congruent Objects. Psychological Science, 33(2), 299-313. SAGE Publications.

Link to cited source
View post record

Post published on Twitter/X on 13 Jan 2022 13:17

Information about the link integrated into the post

DOI work

Elizabeth Sheppard, Editha van Loon, Danielle Ropar (2023). Dimensions of Self-Reported Driving Difficulty in Autistic and Non-Autistic Adults and their Relationship with Autistic Traits. Journal of Autism and Developmental Disorders, 53(1), 285-295. Springer Science and Business Media LLC.

Link to cited source
View post record

Post published on Twitter/X on 13 Jan 2022 04:23

Information about the links integrated into the post

Clinical trial

Institut de Recherches Internationales Servier, ADIR, a Servier Group company (2018). Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children Aged From 2 to Less Than 7 Years Old With Autism Spectrum Disorder.. ClinicalTrials.gov. Institut de Recherches Internationales Servier.

Link to cited source
Clinical trial

Institut de Recherches Internationales Servier, ADIR, a Servier Group company (2018). Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children and Adolescents Aged From 7 to Less Than 18 Years Old With Autism Spectrum Disorder. ClinicalTrials.gov. Institut de Recherches Internationales Servier.

Link to cited source
View post record